YC-backed Helios: 1,000+ protein biomarkers from a drop of blood, read by an AI agent
jgooten · x · 2026-11-19
Helios, founded by Billy Evans and backed by Y Combinator and Formation VC, launched its product: users self-collect a drop of blood at home with a painless, needle-free device; the company measures 1,000+ protein biomarkers carrying signals from cells and organs throughout the body, and a Helios AI agent explains the results, highlights risks, and offers personalized guidance — aiming to help users live "younger, longer." A waitlist is now open. The retweeter, who knew the founders in college, vouches that they know what they're doing.
More from AGI Musings
- AI may make customer-facing forward-deployed roles more valuable, not less — ivory_tang · 2026-11-19
- Ex-SOTA LLM builder: UK AI is held back by risk-averse capital and 'insane regulation' — rosstaylor90 · 2026-11-19
- Counter-take to "LLs have peaked": new models much better at long-horizon tasks — minhnguyen · 2026-11-19
- Running 15 AI Agents All Day Is Context-Switching Fatigue, IBM Engineer Explains — TejasKumar_ · 2026-11-19
- UK missed the frontier-model window? Debate over pivoting to today's AI opportunities — rosstaylor90 · 2026-11-19
- signull: AI products are text-optimized; visual experiences will be the next big shift — signulll · 2026-11-19